FDA Clearance Tracker · P040029-S021
Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear, Euclid Orthokeratology (tisilfocon A) Contact Le
Last checked: Nov 20, 2026Latest source record: Mar 6, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Mar 6, 2026
Approved
Time to decision
1,040 days
Received May 1, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P040029-S021
- Device name
- Euclid Orthokeratology (oprifocon A) Contact Lenses for Overnight Wear, Euclid Orthokeratology (tisilfocon A) Contact Le
- Applicant
- Euclid Vision Corporation
- Applicant location
- Sterling, VA
- Received
- May 1, 2023
- Decided
- Mar 6, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P040029
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.5916
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
approval for toric periphery orthokeratology contact lens
Source documents
Other decisions for Euclid Vision Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.